Work

Adherence to EndoPredict test scores for extended endocrine therapy management in the prospective EndoPredict Extended Endocrine Trial (EXET).

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.537

Authors: Adam Brufsky, Lauren Lenz, Anita Pudusseri, David Wright, Kashyap B. Patel, Brad T. Clifford, Tracey L. O'Connor, Sasha Strain, Fadi Kayali, Sarah Ratzel, Shelly Cummings, Ralf Kronenwett, Thomas Paul Slavin

Institutions: University of Pittsburgh Medical Center, Myriad Genetics, Boston University, Boston Medical Center, Summa Health System, Roswell Park Comprehensive Cancer Center, The University of Texas Medical Branch at Galveston

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Myriad Genetics

OpenAlex ID: W4286299130

Cites:

Cited by: 5

Related to: 10